Provided by Tiger Fintech (Singapore) Pte. Ltd.

FOSUN PHARMA

14.540
+0.5604.01%
Volume:4.12M
Turnover:59.08M
Market Cap:38.72B
PE:13.22
High:14.540
Open:14.120
Low:14.060
Close:13.980
Loading ...

Chinese regulator Accepts New Drug Applications from Shanghai Fosun Pharmaceutical's Two Subsidiaries

MT Newswires Live
·
10 Feb

Fosun Pharma Unit Gets China Clinical Trial Approval for COPD Treatment

MT Newswires Live
·
07 Feb

Fosun Pharmaceutical Gains EU Marketing Approval for Lung Cancer Drug

MT Newswires Live
·
06 Feb

Shanghai Fosun Pharmaceutical Arm Gets Registration for Anti-Bronchospasm Drug in China

MT Newswires Live
·
24 Jan

Fosun Pharmaceutical to Repurchase Shares in Hong Kong, Shanghai

MT Newswires Live
·
23 Jan

Henlius Biotech's Merger Contract with Fosun Pharma Falls Through; Shares Fall 4%

MT Newswires Live
·
23 Jan

BUZZ-Shanghai Henlius Biotech at 9-month low as shareholders reject buyout offer

Reuters
·
23 Jan

Shanghai Fosun Pharmaceutical Unit Gets China Nod for Anxiety Relief Tablets

MT Newswires Live
·
21 Jan

Fosun Pharma Unit Gets China Marketing Nod for Hypotension Drug

MT Newswires Live
·
21 Jan

Shanghai Fosun Pharma Unit Starts Phase 2 Trial for Kidney Filtration System Disease Drug

MT Newswires Live
·
15 Jan

Fosun Pharmaceutical's Unit Gets China Nod for Registration of Breast Cancer Drug

MT Newswires Live
·
09 Jan

Shanghai Fosun Pharmaceutical (Group) Subsidiary's Cancer Drug's NDA Accepted by NMPA

MT Newswires Live
·
03 Jan

Regent Pacific's Strategic Partners Submits NDA for Premature Ejaculation Drug in China

MT Newswires Live
·
18 Dec 2024

Fosun Pharmaceutical Buys Back Nearly 3 Million Yuan Worth of Shares

MT Newswires Live
·
13 Dec 2024

Shanghai Fosun Pharmaceutical Obtains Authorization for New Indication of Hans-Zhong Drug

MT Newswires Live
·
04 Dec 2024

Shanghai Fosun Pharmaceutical (Group)'s Blood Health Medication Gets NMPA's Nod

MT Newswires Live
·
03 Dec 2024

Shanghai Fosun Pharmaceutical (Group) Unit's Cervical Dystonia Gets NMPA Nod

MT Newswires Live
·
28 Nov 2024

Fosun Pharma Gets Marketing Authorization for Botox Injection

MT Newswires Live
·
28 Nov 2024

Hangzhou Jiuyuan Gene Engineering Launches Up to HK$570 Million Hong Kong IPO

MT Newswires Live
·
20 Nov 2024

China Accepts Fosun Pharma's Application for Antibiotic, Anti-Leukemia Injections

MT Newswires Live
·
04 Nov 2024